2017 looks set to be a big year for the cannabis industry in both Canada and the US. Canada is moving toward the legalization and regulation of cannabis, and the same is happening in more and more American states.
Maryland is one state that seems to be moving quickly toward legalization. In a news conference on January 30, lawmakers proposed an amendment to the state’s constitution that, if approved, will let voters decide in 2018 whether or not marijuana should be legalized. If it passes, Maryland could become the first state in the region with a “full-fledged” legal marijuana market.
According to The Baltimore Sun, it’s likely that Maryland residents will legalize marijuana if given the choice. David Moon, a Montgomery County Democrat who is leading the charge on the proposed amendment, told the publication, “it’s a matter of when.” He added, “[i]t’s become very clear that this is no longer a fringe issue. It’s totally mainstream.”


The proposal for the amendment is still being drafted, and because it’s a constitutional amendment it will require more support than regular legislation — three-fifths of the state’s Democrat-dominated legislature will need to vote in its favor.
Moon’s proposed amendment is separate from two bills put forward recently that would regulate and tax marijuana in the state. Law Street Media notes that the recommendations made in those bills include granting usage rights to adults over the age of 21 and making it illegal to consume marijuana in public. The bills also call for an excise tax of $30 per ounce and a 9-percent sales tax on retail products.
Other bills aimed at legalizing marijuana in Maryland have failed over the last several years, and Moon’s goal in proposing the amendment is to take the decision out of the government’s hands and allow those in the state to vote directly on the issue.
At least some Maryland lawmakers seem open to the idea of voting the amendment through and allowing voters to dictate whether marijuana is legalized or not. For example, Thomas V. Mike Miller, a southern Maryland Democrat and Senate president, told the Sun that he doesn’t have any objections regarding a constitutional amendment on marijuana legalization.
Meanwhile, Senate Minority Whip Stephen S. Hershey told the news outlet, “I’m all for the expansion of citizens initiatives, but I really think we should we start with the ability to petition any new budget matters — such as newly imposed taxes.”

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 


Maryland isn’t the only state moving closer to legalizing marijuana. On Monday (February 6), a proposal to legalize adult use of marijuana in New Mexico got the go ahead from the first of three committees it needs to get through before it reaches a floor vote.
The Daily Chronic notes that the bill was first approved by the House Consumer and Public Affairs Committee in January, and is now waiting for a review from the House Business and Industry Committee.
If passed, it will allow adults over 21 to possess up to 1 ounce of marijuana in public and 2 ounces at home. The bill will also allow adults to grow up to six marijuana plants at home, with a maximum of 12 plants per household. Under the bill, retail sales will begin in 2019, and will be subject to a 15-percent sales tax; local communities will be allowed to impose an extra 5-percent sales tax.
Investors — and consumers — will no doubt be watching to see what progress is made in both of those states.
Don’t forget to follow us @INN_Resource for real-time news updates.
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to provide a corporate update on its psychedelic pharmaceuticals program. Since its inception, the Company has built a unique product pipeline for novel uses of ketamine, psilocybin and undisclosed psychedelics. PharmaTher is positioning itself to partner its psilocybin program and panaceAI™, and focus on advancing its novel ketamine product pipeline in Parkinson’s disease, depression and pain via the U.S. Food and Drug Administration (“FDA”) regulatory pathway.

“We have made tremendous progress over the last several months that saw our product pipeline evolve to focus on the massive opportunity and potential of ketamine, an FDA approved drug with a known safety profile, to treat significant unmet medical needs for Parkinson’s disease, depression and pain,” said Fabio Chianelli, CEO of PharmaTher. “With our focus on ketamine through repurposing, combining it with an FDA approved drug and delivering it with our novel microneedle delivery system, we are now positioned to expedite our clinical development objectives by taking advantage of the FDA’s 505(b)(2) regulatory pathway and commercializing disruptive ketamine treatments for mental health and pain disorders.”

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), an emerging leader in reducing the carbon footprint of cement products using natural pozzolans, is pleased to announce it has sold and optioned a combined total of 10 million of its 10.5 million shares of Snow Lake Resources.

The sale and option agreements were made with two arms-length purchasers. The first sale was for 1,700,000 shares at $0.04 per share for a total of $68,000 and includes an option granted by PLAN entitling the same party to purchase an additional 4,966,666 shares at $0.04 per share until May 11, 2021 . The second sale was for 1,250,000 shares at $0.04 per share for a total of $50,000 and includes an option granted by PLAN to such party to purchase an additional 2,083,334 shares until August 14, 2021 . As at the date of this news release, PLAN has received $116,000 and will receive another $284,000 if the remaining shares are purchased under the option agreements.

Keep reading... Show less

First Products to Hit California Shelves in Q2 2021

 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that its fully funded state of the art 185,000 square foot production facility in Commerce, California is nearing completion and will be ready to serve the $3b California cannabis market in Q2 2021. The project is on target to be completed in April 2021 with the Company planning for the first of its full line of edibles, tinctures and vape products to be on California retail shelves by May.

Keep reading... Show less

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders – potential industry partners, shareholders and prospective investors – by increasing awareness of its remarkable natural mustard-derived crop protection products.

TODAY: The Future of Food Investment Conference – SnowCap Ventures
Tuesday, Nov. 24th at 1:50 pm ET
Investors Register Here

Keep reading... Show less

Sales to Commence Immediately at The Apothecarium Phillipsburg

 TerrAscend Corp. (“TerrAscend”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it has received the final permit from the NJ Department of Health (“NJ DOH”) to dispense medical cannabis from its first dispensary in New Jersey . The 3,500 square-foot dispensary, located at 55 South Main Street in downtown Phillipsburg is situated in the historic Phillipsburg National Bank & Trust building and is the first Alternative Treatment Center (“ATC”) in Warren County .

Keep reading... Show less